Mechanically induced amorphization of drugs: A study of the thermal behavior of cryomilled compounds

AAPS PharmSciTech

Volumn 13, Issue 3, 2012, Pages 772-784

  Trasi, Niraj S ^a   Byrn, Stephen R ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

amorphous; cryomilling; crystallization; thermal analysis

Indexed keywords

CARBAMAZEPINE; GRISEOFULVIN; INDOMETACIN; KETOCONAZOLE; PIROXICAM; URSODEOXYCHOLIC ACID;

AMORPHIZATION; ARTICLE; CHEMICAL PHENOMENA; CONTROLLED STUDY; CRYSTALLIZATION; DIFFERENTIAL SCANNING CALORIMETRY; GROWTH RATE; MECHANICAL STRESS; MICROSCOPY; PRIORITY JOURNAL; THERMAL ANALYSIS; X RAY POWDER DIFFRACTION;

CHEMISTRY, PHARMACEUTICAL; CRYSTALLIZATION; DIFFERENTIAL THERMAL ANALYSIS; PHARMACEUTICAL PREPARATIONS; X-RAY DIFFRACTION;

EID: 84866141766     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-012-9801-8     Document Type: Article

References (45)

1. Haleblian J, McCrone W. Pharmaceutical applications of polymorphism. J Pharm Sci. 1969;58(8):911-29.
2. Morris KR, Griesser UJ, Eckhardt CJ, Stowell JG. Theoretical approaches to physical transformations of active pharmaceutical ingredients during manufacturing processes. Adv Drug Deliv Rev. 2001;48(1):91-114.
3. Lin SY, Hsu CH, Ke WT. Solid-state transformation of different gabapentin polymorphs upon milling and co-milling. Int J Pharm. 2010;396(1-2):83-90.
4. Otsuka M, Matsumoto T, Kaneniwa N. Effect of environmental temperature on polymorphic solid-state transformation of indomethacin during grinding. Chem Pharm Bull. 1986;34(4):1784-93.
5. Willart JF, De Gusseme A, Hemon S, Odou G, Danede F, Descamps M. Direct crystal to glass transformation of trehalose induced by ball milling. Solid State Commun. 2001;119(8-9):501-5.
6. Longuemard P, Jbilou M, Guyot-Hermann AM, Guyot JC. Ground and native crystals: comparison of compression capacity and dissolution rate. Int J Pharm. 1998;170(1):51-61.
7. Duddu SP, Grant DJW. The use of thermal-analysis in the assessment of crystal disruption. Thermochim Acta. 1995;248:131-45.
8. Ward GH, Schultz RK. Process-induced crystallinity changes in albuterol sulfate and its effect on powder physical stability. Pharm Res. 1995;12(5):773-9.
9. Shalaev E, Shalaeva M, Zografi G. The effect of disorder on the chemical reactivity of an organic solid, tetraglycine methyl ester: change of the reaction mechanism. J Pharm Sci. 2002;91(2):584-93.
10. Wildfong PLD, Hancock BC, Moore MD, Morris KR. Towards an understanding of the structurally based potential for mechanically activated disordering of small molecule organic crystals. J Pharm Sci. 2006;95(12):2645-56.
11. Willart JF, Descamps M. Solid state amorphization of pharmaceuticals. Mol Pharm. 2008;5(6):905-20.
12. Otsuka M, Kaneniwa N. A kinetic study of the crystallization process of noncrystalline indomethacin under isothermal conditions. Chem Pharm Bull. 1988;36(10):4026-32.
13. Bates S, Zografi G, Engers D, Morris K, Crowley K, Newman A. Analysis of amorphous and nanocrystalline solids from their X-ray diffraction patterns. Pharm Res. 2006;23(10):2333-49.
14. Feng T, Bates S, Carvajal MT. Toward understanding the evolution of griseofulvin crystal structure to a mesophase after cryogenic milling. Int J Pharm. 2009;367(1-2):16-9.
15. Feng T, Pinal R, Carvajal MT. Process induced disorder in crystalline materials: differentiating defective crystals from the amorphous form of griseofulvin. J Pharm Sci. 2008;97(8):3207-21.
16. Qi S, Weuts I, De Cort S, Stokbroekx S, Leemans R, Reading M, et al. An investigation into the crystallisation behaviour of an amorphous cryomilled pharmaceutical material above and below the glass transition temperature. J Pharm Sci. 2010;99(1):196-208.
17. Trasi NS, Boerrigter SXM, Byrn SR. Investigation of the milling-induced thermal behavior of crystalline and amorphous griseofulvin. Pharm Res. 2010;27(7):1377-89.
18. Zili Z, Sfar S, Fessi H. Preparation and characterization of poly-e-caprolactone nanoparticles containing griseofulvin. Int J Pharm. 2005;294(1-2):261-7.
19. Zhu L, Brian CW, Swallen SF, Straus PT, Ediger MD, Yu L. Surface Self-Diffusion of an Organic Glass. Phys Rev Lett. 2011;106:256103-1-4.
20. Nicolai B, Ceolin R, Rietveld IB. Polymorphism and solvation of indomethacin. J Therm Anal Calorim. 2010;102(1):211-6.
21. Crowley KJ, Zografi G. Cryogenic grinding of indomethacin polymorphs and solvates: assessment of amorphous phase formation and amorphous phase physical stability. J Pharm Sci. 2002;91(2):492-507.
22. Rani M, Govindarajan R, Surana R, Suryanarayanan R. Structure in dehydrated trehalose dihydrateevaluation of the concept of partial crystallinity. Pharm Res. 2006;23(10):2356-67.
23. Viseras C, Salem II, Galan ICR, Galan AC, Galindo AL. The effect of recrystallization on the crystal growth, melting point and solubility of ketoconazole. Thermochim Acta. 1995;268:143-51.
24. Yonemochi E, Ueno Y, Ohmae T, Oguchi T, Nakajima S, Yamamoto K. Evaluation of amorphous ursodeoxycholic acid by thermal methods. Pharm Res. 1997;14(6):798-803.
25. Yonemochi E, Inoue Y, Buckton G, Moffat A, Oguchi T, Yamamoto K. Differences in crystallization behavior between quenched and ground amorphous ursodeoxycholic acid. Pharm Res. 1999;16(6):835-40.
26. Kaneniwa N, Yamaguchi T, Watari N, Otsuka M. Hygroscopicity of carbamazepine crystalline powders. Yakugaku Zasshi-J Pharm Soc Jpn. 1984;104(2):184-90.
27. Krahn FU, Mielck JB. Relations between several polymorphic forms and the dihydrate of carbamazepine. Pharmaceutica Acta Helvetiae. 1987;62(9):247-54.
28. Umeda T, Ohnishi N, Yokoyama T, Kuroda K, Kuroda T, Tatsumi E, et al. Kinetics of the thermal transition of carbamzepine polymorphic forms in the solid state. Yakugaku Zasshi-J Pharm Soc Jpn. 1984;104(7):786-92.
29. McMahon LE, Timmins P, Williams AC, York P. Characterization of dihydrates prepared from carbamazepine polymorphs. J Pharm Sci. 1996;85(10):1064-9.
30. Ishida H, Wu TA, Yu LA. Sudden rise of crystal growth rate of nifedipine near Tg without and with polyvinylpyrrolidone. J Pharm Sci. 2007;96(5):1131-8.
31. Wu T, Yu L. Origin of enhanced crystal growth kinetics near Tg probed with indomethacin polymorphs. J Phys Chem B. 2006;110(32):15694-9.
32. Okui N. Relationship between crystallization temperature and melting temperature in crystalline materials. J Mater Sci. 1990;25(3):1623-31.
33. Baird JA, Van Eerdenbrugh B, Taylor LS. A classification system to assess the crystallization tendency of organic molecules from undercooled melts. J Pharm Sci. 2010;99(9):3787-806.
34. Zhou DL, Zhang GGZ, Law D, Grant DJW, Schmitt EA. Physical stability of amorphous pharmaceuticals: importance of configurational thermodynamic quantities and molecular mobility. J Pharm Sci. 2002;91(8):1863-72.
35. Wu T, Yu L. Surface crystallization of indomethacin below Tg. Pharm Res. 2006;23(10):2350-5.
36. Zhu L, Wong L, Yu L. Surface-enhanced crystallization of amorphous nifedipine. Mol Pharm. 2008;5(6):921-6.
37. Zhu L, Jona J, Nagapudi K, Wu TA. Fast surface crystallization of amorphous griseofulvin below T (g). Pharm Res. 2010;27(8):1558-67.
38. Willart JF, Carpentier L, Dannede F, Descamps M. Solid-state vitrification of crystalline griseofulvin by mechanical milling. J Pharm Sci. 2012;101(4):1570-7.
39. Chattoraj S, Bhugra C, Telang C, Zhong L, Wang ZR, Sun CC. Origin of two modes of non-isothermal crystallization of glasses produced by milling. Pharm Res. 2012;29(4):1020-32.
40. Zhou D, Zhang GGZ, Law D, Grant DJW, Schmitt EA. Thermodynamics, molecular mobility and crystallization kinetics of amorphous griseofulvin. Mol Pharm. 2008;5(6):927-36.
41. Vrecer F, Vrbinc M, Meden A. Characterization of piroxicam crystal modifications. Int J Pharm. 2003;256(1-2):3-15.
42. Korhonen O, Bhura C, Pikal MJ. Correlation between molecular mobility and crystal growth of amorphous phenobarbital and phenobarbital with polyvinylpyrrolidone and L-proline. J Pharm Sci. 2008;97(9):3830-41.
43. Ediger MD, Angell CA, Nagel SR. Supercooled liquids and glasses. J Phys Chem. 1996;100(31):13200-12.
44. Crowley KJ, Zografi G. The use of thermal methods for predicting glass-former fragility. Thermochim Acta. 2001;380(2):79-93.
45. Desprez S, Descamps M. Transformations of glassy indomethacin induced by ball-milling. J Non-Cryst Solids. 2006;352(42-49):4480-5.